Ann: Extension for Voluntary Suspension, page-148

Hi Suzuki, not selling Admedus short at all mate, nothing wrong with tempering expectations, this current negotiation/s is a massive task WP is undertaking.

I also recognise, to some extent, the difficulties facing WP, nobody can discount then.

Big positives WP has is virtually no debt, and very promising IP, sale of MDD gave the company a breathing space, obviously.

I realise the hurdles of investing in this field and the ‘nature of the beast’, my point was this; if a stock could rise after a CR with just hype what could it do with solid fundamentals behind it??..... yes?

I was being modest with the 20 mill plus call mate, not wishing to pie in the sky either, point being enough funds must arrive to give this company stability.

With that stability and tie up with a major entity the ‘whole perception of Admedus’ should change, perception that will turn it around, perception not based on hype.